273 related articles for article (PubMed ID: 23740299)
1. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells.
Suades R; Padró T; Alonso R; Mata P; Badimon L
Thromb Haemost; 2013 Aug; 110(2):366-77. PubMed ID: 23740299
[TBL] [Abstract][Full Text] [Related]
2. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
[TBL] [Abstract][Full Text] [Related]
3. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
Suades R; Padró T; Alonso R; Mata P; Badimon L
Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
[TBL] [Abstract][Full Text] [Related]
5. CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts.
Chiva-Blanch G; Crespo J; Suades R; Arderiu G; Padro T; Vilahur G; Cubedo J; Corella D; Salas-Salvadó J; Arós F; Martínez-González MA; Ros E; Fitó M; Estruch R; Badimon L
Thromb Haemost; 2016 Jul; 116(1):103-14. PubMed ID: 27052787
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
8. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
Clearfield MB
J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192
[TBL] [Abstract][Full Text] [Related]
9. Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease.
Satoh M; Minami Y; Takahashi Y; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2009 May; 116(11):827-35. PubMed ID: 19090788
[TBL] [Abstract][Full Text] [Related]
10. The effect of decreasing statin's dosage on LDL-C levels after target levels achieved.
Tan TY
Acta Neurol Taiwan; 2013 Sep; 22(3):99-105. PubMed ID: 24030088
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
[TBL] [Abstract][Full Text] [Related]
12. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
13. The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.
Nomura S; Inami N; Shouzu A; Omoto S; Kimura Y; Takahashi N; Tanaka A; Urase F; Maeda Y; Ohtani H; Iwasaka T
Platelets; 2009 Feb; 20(1):16-22. PubMed ID: 19172517
[TBL] [Abstract][Full Text] [Related]
14. Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients.
Nomura S; Shouzu A; Omoto S; Inami N; Shimazu T; Satoh D; Kajiura T; Yamada K; Urase F; Maeda Y; Iwasaka T
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):440-7. PubMed ID: 19525846
[TBL] [Abstract][Full Text] [Related]
15. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
[TBL] [Abstract][Full Text] [Related]
17. Intensive statin therapy for Indians: Part-I. Benefits.
Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
[TBL] [Abstract][Full Text] [Related]
18. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
19. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease.
Feringa HH; Karagiannis SE; van Waning VH; Boersma E; Schouten O; Bax JJ; Poldermans D
J Vasc Surg; 2007 May; 45(5):936-43. PubMed ID: 17360142
[TBL] [Abstract][Full Text] [Related]
20. Statins have beneficial effects on platelet free radical activity and intracellular distribution of GTPases in hyperlipidaemia.
Hamilton PK; Hughes SM; Plumb RD; Devine A; Leahey W; Lyons KS; Johnston D; McVeigh GE
Clin Sci (Lond); 2010 Mar; 118(5):359-66. PubMed ID: 19740072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]